Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/12/2002WO2002099135A1 Method to measure gene expression ratio of key genes
12/12/2002WO2002099134A1 Methods and compositions for assessment of pulmonary function and disorders
12/12/2002WO2002099133A1 Improved method for detecting and identifying microorganism causative of infection
12/12/2002WO2002099131A1 Transcription factor binding element
12/12/2002WO2002099125A1 PIBs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099122A1 Modifiers of the p53 pathway and methods of use
12/12/2002WO2002099120A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/12/2002WO2002099119A2 B7-related nucleic acids and polypeptides useful for immunomodulation
12/12/2002WO2002099118A2 Method of identifying a polymorphism in cyp2d6
12/12/2002WO2002099115A2 Nucleic acid-associated proteins
12/12/2002WO2002099112A2 Lipoxygenase overexpression in plants and reduction in plant sensitivity to diseases and attacks from pathogenic organisms
12/12/2002WO2002099111A2 Anther-specific taa1 genes encoding fatty acyl co-a reductases, and uses thereof
12/12/2002WO2002099110A1 Cell cycle regulatory factor
12/12/2002WO2002099109A1 Novel polypeptide, dna encoding the polypeptide and use thereof
12/12/2002WO2002099108A2 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002WO2002099107A2 Regulation of human trace amine receptor ta5
12/12/2002WO2002099106A2 Regulation of human secretin -type gpcr
12/12/2002WO2002099105A2 Methods for modifying the cpg content of polynucleotides
12/12/2002WO2002099103A1 Novel genes and proteins encoded thereby
12/12/2002WO2002099102A1 Numb protein expression inhibitors by musashi
12/12/2002WO2002099101A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
12/12/2002WO2002099099A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
12/12/2002WO2002099097A1 Novel compounds for chemiluminescense procedures
12/12/2002WO2002099095A2 Improved isoprenoid production
12/12/2002WO2002099094A2 Human serine/threonine protein kinase-like enzyme
12/12/2002WO2002099092A2 Production of recombinant human lysosomal alpha-mannosidase
12/12/2002WO2002099091A2 Endo-beta-1,4-glucanase from bacillus
12/12/2002WO2002099090A1 Bcl-2 dnazymes
12/12/2002WO2002099089A1 Compositions and methods for high-level, large-scale production of recombinant proteins
12/12/2002WO2002099088A1 Double-transfected cell line useful for the identification of transport inhibitors
12/12/2002WO2002099086A1 Industrially useful microorganisms
12/12/2002WO2002099083A2 Gfats as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099082A2 Expression of spider silk proteins in higher plants
12/12/2002WO2002099080A2 Methods for low background cloning of dna using long oligonucleotides
12/12/2002WO2002099079A2 Cytokinin response regulators and uses thereof
12/12/2002WO2002099076A2 Sugar and lipid metabolism regulators in plants ii
12/12/2002WO2002099075A2 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099074A2 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099070A2 Compositions and methods for high-level, large-scale production of recombinant proteins
12/12/2002WO2002099068A2 Lces as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099067A2 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
12/12/2002WO2002099064A2 Rna purification methods
12/12/2002WO2002099063A2 Alteration of embryo/endosperm size during seed development
12/12/2002WO2002099060A2 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099059A2 U5-200KDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099058A2 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099057A2 Sams modifiers of the p53 pathway and methods of use
12/12/2002WO2002099056A2 C22c7orfs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099055A2 Cips as modifiers of the p53 pathway and method of use
12/12/2002WO2002099054A2 Hccss as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099053A2 Slc22as as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099052A2 Opns as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099051A2 Nits as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099050A2 Tprs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099049A2 Tbc1d1s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099048A2 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099047A2 PROMLs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099046A2 Spo11 as modifier of the p53 pathway and methods of use
12/12/2002WO2002099044A2 B3galts as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099043A2 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099042A2 Cads as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099041A2 Ces2s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099040A2 Igs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099038A2 Adsls as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099037A2 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
12/12/2002WO2002099036A2 Inhibition of neurodegeneration
12/12/2002WO2002099035A2 Chimeric alphavirus replicon particles
12/12/2002WO2002099034A2 Sequences for detection and identification of methicillin-resistant staphyloccocus aureus
12/12/2002WO2002098921A1 Recombinant antibodies against infectious bursal disease virus (ibdv)
12/12/2002WO2002098920A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002WO2002098917A2 Human proteins and nucleic acids encoding same
12/12/2002WO2002098916A2 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
12/12/2002WO2002098914A2 Mutants of igf binding proteins and methods of production of antagonists thereof
12/12/2002WO2002098911A2 Insecticidal proteins and synergistic combinations thereof
12/12/2002WO2002098908A2 Osteoclastogenesis inhibitory factor, sequence coding for it and uses
12/12/2002WO2002098907A2 Cation conducting gabaa receptors and their use
12/12/2002WO2002098899A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098898A2 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098897A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
12/12/2002WO2002098891A2 GADs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098890A2 MARKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098889A2 MAP3Ks AS MODIFIER OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098468A1 SLC13As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098467A1 Slc2as as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098466A1 Replicating adenovirus vectors
12/12/2002WO2002098457A2 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
12/12/2002WO2002098456A2 Antigens and vectors for vaccination
12/12/2002WO2002098455A2 Production of recombinant human arylsulfatase a
12/12/2002WO2002098444A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
12/12/2002WO2002098443A2 Stabilised mrna with an increased g/c content and optimised codon for use in gene therapy
12/12/2002WO2002098432A1 Methods of treating cardiac disorders
12/12/2002WO2002098369A2 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002WO2002098368A2 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002WO2002098365A2 Conditioned cell culture media and uses thereof
12/12/2002WO2002098362A2 Use of rank antagonists to treat cancer
12/12/2002WO2002098361A2 T cell induced tissue repair and regeneration
12/12/2002WO2002098360A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
12/12/2002WO2002098356A2 Ppp2cs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098355A2 Methods and reagents for diagnosis and treatment of insulin resistance and related conditions
12/12/2002WO2002098346A2 Method and pharmaceutical composition for the treatment of multiple sclerosis
1 ... 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 ... 4023